OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy
Xiaomin Wang, Brian Walitt, Leorey N. Saligan, et al.
Cytokine (2015) Vol. 72, Iss. 1, pp. 86-96
Open Access | Times Cited: 169
Xiaomin Wang, Brian Walitt, Leorey N. Saligan, et al.
Cytokine (2015) Vol. 72, Iss. 1, pp. 86-96
Open Access | Times Cited: 169
Showing 1-25 of 169 citing articles:
Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 189
Theoharis C. Theoharides, Christos Cholevas, Konstantinos S. Polyzoidis, et al.
BioFactors (2021) Vol. 47, Iss. 2, pp. 232-241
Open Access | Times Cited: 189
Mechanisms of Chemotherapy-Induced Neurotoxicity
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 134
Halina Waś, Agata Borkowska, Ana Bagüés, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 134
Chemotherapy: how to reduce its adverse effects while maintaining the potency?
Brianna Brianna, Sau Har Lee
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 86
Brianna Brianna, Sau Har Lee
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 86
Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 128
Lien D. Nguyen, Barbara E. Ehrlich
EMBO Molecular Medicine (2020) Vol. 12, Iss. 6
Open Access | Times Cited: 128
Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study
Kimberly D. van der Willik, Vincent Koppelmans, Michael Hauptmann, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 123
Kimberly D. van der Willik, Vincent Koppelmans, Michael Hauptmann, et al.
Breast Cancer Research (2018) Vol. 20, Iss. 1
Open Access | Times Cited: 123
Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer
Krystal English, Andrew J. Shepherd, Ndidi-Ese Uzor, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 123
Krystal English, Andrew J. Shepherd, Ndidi-Ese Uzor, et al.
Acta Neuropathologica Communications (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 123
Pifithrin-μ Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function
Gabriel S. Chiu, Magdalena Maj, Sahar Rizvi, et al.
Cancer Research (2016) Vol. 77, Iss. 3, pp. 742-752
Open Access | Times Cited: 103
Gabriel S. Chiu, Magdalena Maj, Sahar Rizvi, et al.
Cancer Research (2016) Vol. 77, Iss. 3, pp. 742-752
Open Access | Times Cited: 103
Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments
Jéssica Cristina dos Santos, Leah M. Pyter
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 101
Jéssica Cristina dos Santos, Leah M. Pyter
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 101
Taxane‐induced neurotoxicity: Pathophysiology and therapeutic perspectives
Robson da Costa, Giselle F. Passos, Nara Lins Meira Quintão, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3127-3146
Open Access | Times Cited: 99
Robson da Costa, Giselle F. Passos, Nara Lins Meira Quintão, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 14, pp. 3127-3146
Open Access | Times Cited: 99
Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus
Ciara Bagnall-Moreau, Sovira Chaudhry, Kaliris Y. Salas-Ramirez, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7159-7172
Open Access | Times Cited: 93
Ciara Bagnall-Moreau, Sovira Chaudhry, Kaliris Y. Salas-Ramirez, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 10, pp. 7159-7172
Open Access | Times Cited: 93
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 78
Sara Emad El-Agamy, Amal Kamal Abdel‐Aziz, Ahmed Esmat, et al.
Cancer Chemotherapy and Pharmacology (2019) Vol. 84, Iss. 1, pp. 1-14
Closed Access | Times Cited: 78
Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Jiajia Du, Aoxue Zhang, Jing Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 76
Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
Benjamin Ongnok, Thawatchai Khuanjing, Titikorn Chunchai, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 2107-2125
Open Access | Times Cited: 57
Benjamin Ongnok, Thawatchai Khuanjing, Titikorn Chunchai, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 2107-2125
Open Access | Times Cited: 57
Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice
TaeHyun Kim, Benjamin T. James, Martin C. Kahn, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 737
Open Access | Times Cited: 12
TaeHyun Kim, Benjamin T. James, Martin C. Kahn, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 737
Open Access | Times Cited: 12
Senolytic treatment alleviates doxorubicin‐induced chemobrain
Vivekananda Budamagunta, Ashok Kumar, Asha Rani, et al.
Aging Cell (2024) Vol. 23, Iss. 2
Open Access | Times Cited: 9
Vivekananda Budamagunta, Ashok Kumar, Asha Rani, et al.
Aging Cell (2024) Vol. 23, Iss. 2
Open Access | Times Cited: 9
Dysregulation of cytokine mediated chemotherapy induced cognitive impairment
Xiaojia Ren, Daret K. St. Clair, D. Allan Butterfield
Pharmacological Research (2017) Vol. 117, pp. 267-273
Closed Access | Times Cited: 77
Xiaojia Ren, Daret K. St. Clair, D. Allan Butterfield
Pharmacological Research (2017) Vol. 117, pp. 267-273
Closed Access | Times Cited: 77
The effect of cancer treatment on cognitive function.
Arash Asher, Jamie Myers
PubMed (2015) Vol. 13, Iss. 7, pp. 441-50
Closed Access | Times Cited: 75
Arash Asher, Jamie Myers
PubMed (2015) Vol. 13, Iss. 7, pp. 441-50
Closed Access | Times Cited: 75
Ginsenoside Rg1 Prevents Chemotherapy-Induced Cognitive Impairment: Associations with Microglia-Mediated Cytokines, Neuroinflammation, and Neuroplasticity
Dongdong Shi, Yuhua Huang, Cora Sau Wan Lai, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5626-5642
Closed Access | Times Cited: 70
Dongdong Shi, Yuhua Huang, Cora Sau Wan Lai, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 8, pp. 5626-5642
Closed Access | Times Cited: 70
Resveratrol, a natural polyphenol, prevents chemotherapy-induced cognitive impairment: Involvement of cytokine modulation and neuroprotection
Dongdong Shi, Celia M. Dong, Leon C. Ho, et al.
Neurobiology of Disease (2018) Vol. 114, pp. 164-173
Closed Access | Times Cited: 64
Dongdong Shi, Celia M. Dong, Leon C. Ho, et al.
Neurobiology of Disease (2018) Vol. 114, pp. 164-173
Closed Access | Times Cited: 64
Chemotherapy-Induced Cognitive Impairment Is Associated with Cytokine Dysregulation and Disruptions in Neuroplasticity
Dongdong Shi, Yuhua Huang, Cora Sau Wan Lai, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 3, pp. 2234-2243
Closed Access | Times Cited: 64
Dongdong Shi, Yuhua Huang, Cora Sau Wan Lai, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 3, pp. 2234-2243
Closed Access | Times Cited: 64
A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL/6 mice
Petra Huehnchen, Wolfgang Boehmerle, Andreas Springer, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 8, pp. e1185-e1185
Open Access | Times Cited: 62
Petra Huehnchen, Wolfgang Boehmerle, Andreas Springer, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 8, pp. e1185-e1185
Open Access | Times Cited: 62
Why Are Objective and Perceived Cognitive Function Weakly Correlated in Patients With Cancer?
Daniel Costa, Joanna E. Fardell
Journal of Clinical Oncology (2019) Vol. 37, Iss. 14, pp. 1154-1158
Closed Access | Times Cited: 59
Daniel Costa, Joanna E. Fardell
Journal of Clinical Oncology (2019) Vol. 37, Iss. 14, pp. 1154-1158
Closed Access | Times Cited: 59
Neuroinflammation disorders exacerbated by environmental stressors
James P. O’Callaghan, Diane B. Miller
Metabolism (2019) Vol. 100, pp. 153951-153951
Open Access | Times Cited: 57
James P. O’Callaghan, Diane B. Miller
Metabolism (2019) Vol. 100, pp. 153951-153951
Open Access | Times Cited: 57
Neurological post‐acute sequelae of SARS‐CoV ‐2 infection
Masaki Takao, Masayuki Ohira
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 2, pp. 72-83
Open Access | Times Cited: 38
Masaki Takao, Masayuki Ohira
Psychiatry and Clinical Neurosciences (2022) Vol. 77, Iss. 2, pp. 72-83
Open Access | Times Cited: 38
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 32
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 32
